Dupilumab efficacy and safety in patients with allergic bronchopulmonary aspergillosis

Study limitation reported by the research below: “Impact flag 'practice changing' applied provisionally — this is a phase 2 trial with no currently approved therapies for ABPA, but phase 3 confirmation is still pending.”